Literature DB >> 11060085

Comparison of the BACTEC MGIT 960 and ESP culture system II for growth and detection of mycobacteria.

N Williams-Bouyer1, R Yorke, H I Lee, G L Woods.   

Abstract

The performances of two continuously monitoring mycobacterial culture systems-ESP Culture System II (ESP II; Trek Diagnostics, Inc. , Westlake, Ohio) and BACTEC MGIT 960 (BD Biosciences, Sparks, Md. )-were compared. In addition to both liquid media, all specimens were plated onto Middlebrook 7H11/7H11 selective agar. A total of 3, 151 specimens of all types (56.3% were respiratory specimens) were cultured; 231 (7.3%) yielded mycobacteria. The most common species recovered were Mycobacterium avium complex (69 isolates) and Mycobacterium tuberculosis complex (MTBC; 65 isolates). The recovery rates for ESP II, BACTEC MGIT 960, and Middlebrook agar, respectively, were 71.2, 63.9, and 61.8% for all mycobacteria; 70.2, 72.6, and 66.3% for all mycobacteria except Mycobacterium gordonae; and 73.8, 84.6, and 87.7% for MTBC. For liquid plus solid medium combinations, recovery rates for all mycobacteria and for MTBC, respectively, were 84.1 and 92.3% for ESP II plus Middlebrook agar and 81.5 and 98.5% for BACTEC MGIT 960 plus Middlebrook agar. The differences in recovery of all mycobacteria by ESP II and by BACTEC MGIT 960 were not significant; for the individual species, the only significant difference was recovery of more isolates of M. gordonae by ESP II. For those isolates recovered in both automated systems, mean times to detection of all mycobacteria and MTBC, respectively, were 15.8 and 17.4 days for ESP II and 12.5 and 11.9 days for BACTEC MGIT 960 (P < 0.05). False-positive signals occurred with 23 (0.7%) BACTEC MGIT 960 cultures and 84 (2.7%) ESP II cultures (P < 0.01). Overall contamination rates were 17.1% for BACTEC MGIT 960, 18.9% for ESP II, and 11.0% for Middlebrook agar. In summary, the ESP II and BACTEC MGIT 960 systems performed comparably with regard to growth and detection of mycobacteria, and the contamination rates were similar. However, with ESP II, times to detection of all mycobacteria and of MTBC were significantly longer, the recovery rate of M. gordonae was significantly higher, and the number of false-positive signals was greater than with BACTEC MGIT 960.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11060085      PMCID: PMC87558     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

1.  Evaluation of the BACTEC MGIT 960 and the MB/BacT systems for recovery of mycobacteria from clinical specimens and for species identification by DNA AccuProbe.

Authors:  F Alcaide; M A Benítez; J M Escribà; R Martín
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Comparison of MB-Check, BACTEC, and egg-based media for recovery of mycobacteria.

Authors:  C Abe; S Hosojima; Y Fukasawa; Y Kazumi; M Takahashi; K Hirano; T Mori
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

3.  Evaluation of the ESP Culture System II for recovery of mycobacteria from blood specimens collected in isolator tubes.

Authors:  C A Tholcken; S Huang; G L Woods
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

4.  Comparison of improved BACTEC and Lowenstein-Jensen media for culture of mycobacteria from clinical specimens.

Authors:  P Anargyros; D S Astill; I S Lim
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

5.  Multicenter comparison of ESP Culture System II with BACTEC 460TB and with Lowenstein-Jensen medium for recovery of mycobacteria from different clinical specimens, including blood.

Authors:  E Tortoli; P Cichero; M G Chirillo; M R Gismondo; L Bono; G Gesu; M T Simonetti; G Volpe; G Nardi; P Marone
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

6.  Clinical evaluation of difco ESP culture system II for growth and detection of mycobacteria.

Authors:  G L Woods; G Fish; M Plaunt; T Murphy
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

7.  The resurgence of tuberculosis: is your laboratory ready?

Authors:  F C Tenover; J T Crawford; R E Huebner; L J Geiter; C R Horsburgh; R C Good
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

8.  Use of BACTEC MGIT 960 for recovery of mycobacteria from clinical specimens: multicenter study.

Authors:  E Tortoli; P Cichero; C Piersimoni; M T Simonetti; G Gesu; D Nista
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

9.  Multicenter evaluation of the BACTEC MGIT 960 system for recovery of mycobacteria.

Authors:  B A Hanna; A Ebrahimzadeh; L B Elliott; M A Morgan; S M Novak; S Rusch-Gerdes; M Acio; D F Dunbar; T M Holmes; C H Rexer; C Savthyakumar; A M Vannier
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

  9 in total
  18 in total

1.  Early detection of negative BACTEC MGIT 960 cultures by PCR-reverse cross-blot hybridization assay.

Authors:  Lucio Romano; Maurizio Sanguinetti; Brunella Posteraro; Fausta Ardito; Giovanni Gesu; Anna Maria Schito; Giovanni Fadda
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

2.  Meta-analysis of BACTEC MGIT 960 and BACTEC 460 TB, with or without solid media, for detection of mycobacteria.

Authors:  M Cruciani; C Scarparo; M Malena; O Bosco; G Serpelloni; C Mengoli
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

3.  Mycobacterium and Aerobic Actinomycete Culture: Are Two Medium Types and Extended Incubation Times Necessary?

Authors:  Patricia J Simner; Kelly A Doerr; Lory K Steinmetz; Nancy L Wengenack
Journal:  J Clin Microbiol       Date:  2016-02-10       Impact factor: 5.948

4.  Rapid and specific detection of Mycobacterium tuberculosis from acid-fast bacillus smear-positive respiratory specimens and BacT/ALERT MP culture bottles by using fluorogenic probes and real-time PCR.

Authors:  Nancimae Miller; Tim Cleary; Günter Kraus; Andrea K Young; Gina Spruill; H James Hnatyszyn
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

5.  Drug susceptibility testing of Mycobacterium tuberculosis by a nitrate reductase assay applied directly on microscopy-positive sputum samples.

Authors:  Humberto R Musa; Marta Ambroggi; Alejandro Souto; K A Kristian Angeby
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

6.  Genotype MTBDRplus for direct detection of Mycobacterium tuberculosis and drug resistance in strains from gold miners in South Africa.

Authors:  Susan E Dorman; Violet N Chihota; James J Lewis; Minty van der Meulen; Barun Mathema; Natalie Beylis; Katherine L Fielding; Alison D Grant; Gavin J Churchyard
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

7.  Use of hydrogen peroxide vapor for deactivation of Mycobacterium tuberculosis in a biological safety cabinet and a room.

Authors:  Leslie Hall; Jonathan A Otter; John Chewins; Nancy L Wengenack
Journal:  J Clin Microbiol       Date:  2006-12-13       Impact factor: 5.948

8.  Advances in the Diagnosis, Treatment and Control of HIV Associated Tuberculosis.

Authors:  Bruce J Kirenga; Duncan M Chanda; Catherine M Muwonge; Getnet Yimer; Francis E Adatu; Philip C Onyebujoh
Journal:  Afr J Infect Dis       Date:  2012

9.  Rapid mycobacterial liquid culture-screening method for Mycobacterium avium complex based on secreted antigen-capture enzyme-linked immunosorbent assay.

Authors:  Sung Jae Shin; Kelly Anklam; Elizabeth J B Manning; Michael T Collins
Journal:  Clin Vaccine Immunol       Date:  2009-03-04

10.  Probability of negative mycobacterium tuberculosis complex cultures based on time to detection of positive cultures: a multicenter evaluation of commercial-broth-based culture systems.

Authors:  Frances C Tyrrell; Gary E Budnick; Thor Elliott; Laura Gillim-Ross; Mary V Hildred; Peggy Mahlmeister; Nicole Parrish; Michael Pentella; Jolene Vanneste; Yun F Wayne Wang; Angela M Starks
Journal:  J Clin Microbiol       Date:  2012-07-25       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.